at the Mandarin Oriental, Washington, D.C.
Ongoing clinical and scientific advances have transformed the field of ADHD. Substantial knowledge has been gained on the neurobiology, heritability, environmental, persistence, comorbidity, psychotherapeutic and pharmacological treatment of ADHD in children, adolescents and adults. This CME-accredited course will feature nationally and internationally renowned ADHD faculty who will educate participants on recent research findings relevant to clinical practice with a focus on improving the quality of care for all patients with ADHD & related disorders.
Course Description: Attention deficit-hyperactivity disorder (ADHD) is a common disorder of childhood that is typically characterized by symptoms of inattentiveness, impulsivity and hyperactivity, as well as other psychological, social, and emotional difficulties. ADHD is associated with substantial functional and quality of life impairments. This includes impaired academic, social and work performance, as well as emotional distress for family members and caregivers.
Traditionally accepted as a childhood disorder, numerous prospective, longitudinal studies demonstrate the persistence of symptoms to an impairing degree in up to 65% of children into adulthood, leading to a prevalence rate in the general adult US population of 4.4%.1,2 Unfortunately, clinicians are not trained to identify the disorder and often overlook a highly prevalent adult psychiatric condition and ascribe symptoms to other disorders or personality types. Thus, adult ADHD is an under recognized and under-treated condition.
PAST MEETING INFORMATION: